Please login to the form below

Not currently logged in
Email:
Password:

Trikafta

This page shows the latest Trikafta news and features for those working in and with pharma, biotech and healthcare.

Vertex’s triple combination CF therapy to become available on the NHS

Vertex’s triple combination CF therapy to become available on the NHS

Although the European licence for Kaftrio, named Trikafta in the US, only covers patients aged 12 years and older, younger children and those over 12 years of age who are not

Latest news

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...